Skip to main content
All lobbying filings

Society for Maternal-Fetal Medicine

Society for Maternal-Fetal Medicine filed a Q1 report for Society for Maternal-Fetal Medicine on April 22, 2026.

Lobbying for Society for Maternal-Fetal Medicine

As filed: SOCIETY FOR MATERNAL-FETAL MEDICINE for SOCIETY FOR MATERNAL-FETAL MEDICINE.

All filings by Society for Maternal-Fetal Medicine · Everything Society for Maternal-Fetal Medicine has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 22, 2026
Expenses
$10,000
What this organization spent lobbying with its own staff. Reported using IRS section 6033(b)(8) definitions (method B): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbying activity 2

FY 2026 and FY 2027 funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Agency for Healthcare Research & Quality, and the Health Resources and Services Administration

inclusion of pregnant and lactating women in clinical trials, federal support for maternal mortality review committees and perinatal quality collaboratives

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem